In SCA1, SCA2, FRDA and MSA-Cpatients, there was a significant reduction in DNsil but much smallercompared with SCA6 patients (Row 6, Fig.1 and Supplementary Figs 3–5). This evidence concerns the gene CACNA1A and multiple system atrophy.